Zensar Technologies and BDI Pharma engage for business growth
Princeton, NJ – January 31st 2012: Zensar Technologies today announced the successful Go Live of the SAP ERP and CRM at BDI Pharma Inc. The project was delivered through a collaborative engagement between BDI Pharma, Inc. and Zensar Technologies, and their teams of SAP and Industry Experts.
This deployment has been achieved with the use ‘Zenlife’ a proprietary accelerator tool, and the use of various solution frameworks, regulatory expertise, and consulting capabilities in Life Sciences which has resulted in significant cost savings and increased capabilities and efficiency for sales and distribution.
ZenLife is a ready-to-use industry specific templatized SAP solution for pharmaceutical companies covering about 80-85 % of the major business processes and manufacturing operations such as OTC, private label, generics, manufacturing / distribution and sale of products ranging from API to formulations (all kinds of dosage forms). The solution is comprehensive and validated for the Pharmaceutical Industry. As a full implementation and testing partner for SAP applications worldwide, Zensar's SAP practice offers complete, end-to-end services extending from pre-implementation planning through maintenance, support, and upgrade.
On the successful completion of the project, Chief Executive and Global Head MRM Nitin Parab said “Zensar’s SAP Methodology is refined overtime over multiple projects for multi-site global execution. Today Zensar’s SAP Pharma Solution ‘Zenlife’ is rated amongst the best in the industry and has a significant market share in SAP’s Pharmaceuticals Installations. Our seamless transition and installation capabilities have already shown results in the form of cost savings for BDI Pharma and we hope to grow this engagement further in the years to come.”
“The level of expertise demonstrated by Zensar, in combination with the entire organization’s proactive approach to issue resolution and system modification, has been critical to the success of our conversion to SAP”, stated William A. Shirey III, Executive Vice President at BDI Pharma.“The collaborative environment established between Zensar and BDI Pharma integration managers has been remarkable and has made the entire process a true team effort.”
BDI has also selected Zensar to deliver the Business Intelligence Strategy and SAP Business Objects Implementation for reporting and dash-boarding. This effort has been planned for Go Live in the coming months.
Zensar Technologies is a Gold Certified and Strategic Value Added Reseller (SVAR) SAP Partner, with over 10 years of deep expertise in developing and delivering SAP services which help clients adopt and extend technology to drive business transformation and achieve their business goals.
Zensar offers value added pre-configured SAP solutions to minimize clients' Total Cost of Ownership, including development and support. These industry specific and pre-configured solutions are available with built in content, tools and methodologies for a cost-effective implementation. Leveraging a unique global development model, Zensar’s SAP Practice delivers functional and technical expertise amplified by best practices for implementation, maintenance, upgrade and enhancement services for end-to-end solutions.
About Zensar Technologies (www.zensar.com)
Zensar Technologies is among the top 20 software services providers from India. Zensar is the world's first enterprise-wide SEI CMM Level 5 Company and was also later certified as a CMMI Level 5 Company with industry expertise that spans Retail, Manufacturing, Banking, Insurance, Energy and Utilities, Media and Connected Services – Government, Education and Healthcare. An RPG Group company, Zensar has more than 6000 employees with sales and operations presence across US, UK, Germany, Sweden, Finland, Middle East, South Africa, Singapore, Australia, China and Japan. The Company delivers comprehensive services in mission-critical applications, enterprise applications, e-business, BPO and Knowledge Services. The Company has developed tools and methodologies, including the proprietary Solution Blue Print (SBP), which enables its clients with innovative business solutions and a rapid 'go-to-market' capability. The Company supports Fortune 500 clients with software business solutions that help them compete in the digital economy.
About BDI Pharma, Inc.( www.bdipharma.com)
Since 1995, BDI Pharma has defined its customer-centric approach to serving the nation's healthcare community through innovative supply solutions, unparalleled customer service, extensive product knowledge, 24/7 emergency availability and urgent-need delivery. An open-access resource for reference material, educational literature, market data and online ordering, bdipharma.com (ivig.com) has become an industry-renowned point of reference. Proprietary programs for specialty veterinarians -- 4legpharma.com; product consignment -- consignadvantage.com; flu pre-booking and general vaccine ordering -- securivax.com; and purchasing/reward programs -- qoreprogram.com and securigam.com round out a family of solutions tailored to the needs of the healthcare community at large. BDI Pharma’s portfolio includes branded and generic specialty biopharmaceuticals, chemotherapy products, vaccines, albumin, IVIG, coagulation factors, high-titer or “hyper” immune globulins, and other specialty injectables. BDI Pharma is recognized as an “ADR,” or Authorized Distributor of Record, for all of the manufacturers it represents.
For further information, please contact:
Hillary Pell, M: 610-329-1261 O: 484-887-8644 Email: hillary.pell@zensar.com
Janki Sampat, M: +91-9764005810 Email: janki.sampat@zensa
Tags: